GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates

Archives of Disease in Childhood

Volumn 80, Issue 5, 1999, Pages 429-432

  Woelfle, Joachim ^a   Berg, Thomas ^a   Bialek, Ralf ^b   Keller, Klaus Michael ^a   Effenberger, Wolfgang ^a   Wagner, Norbert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

GB virus C; Haemophilia; Hepatitis G virus; HIV

Indexed keywords

BLOOD CLOTTING FACTOR; VIRUS RNA;

ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEMOPHILIA; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; INFECTION RISK; MALE; PRIORITY JOURNAL; VIRUS INACTIVATION; VIRUS VIRULENCE;

EID: 0032945527     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.5.429     Document Type: Article

References (20)

1. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Aled 1995;l:564-9.
2. Leary TP, Muerhoff AS, Simons JN, el a!. Sequence and genornic organisation of GBV-C: a no%-el member of the Flaviviridae associated with human non-A-E hepatitis. J Mcd Virol 1996;48:60-7.
3. Linnen J, \Vages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
4. Toshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346: 1131-2.
5. Kao J-H, Chen P-J, Chen D-S. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996;3-17:120.
6. VCbelfle J, Berg T, Keller KM, el al. Persistent hepatitis G virus infection after neonatal transfusion. J Pcdiatr Gastwcnterol A'wir 1998;26:402-7.
7. Schreier E, Hohne M, Kuenkel U, et al. Hepatitis GBV-C sequences in patients infected \vith HCV contaminated anti-D immunoglobulin and among i. v. drug users. J Hepawl 1996:25:385-9.
8. Berg T, Naumann U, Fukumoto T, et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996;62: 711-42.
9. Berg T, Dirla U, Naumann U, et al. Responsiveness of interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hefatol 1996;25:763-8.
10. Jams LM, Davidson F, Hanley JP, et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996;34S:1352-5.
11. Tong CY, Sallam TA, Williams H, et al. Hepatitis G virus RNA and its relation to hepatitis C infection in adult haemophilic patients. BrJHaematol 1997;99:295-7.
12. De Filippi F, Colombo M, Rumi MO, et al High rates of hepatitis G virus infection in multitransfused patients with hemophilia. Blood 1997;90:4634-7.
13. Garcia-Trevijano ER, Lopez-Alcorocho JM, Quintana Al, et al. HGV in coagulation-factor concentrates. Lancet 1996; 348:1032.
14. Wagner, N, Bialek R, Radinger H, et al. Intravenous immunoglobulin in HIV-1 infected haemophilic patients. Arch Dis Child 1992;67:1267-71.
15. Künkel U, Höhne M, Berg T, et al. Quality control study on the performance of GB virus C/hepatitis G virus PCR. J Hepaiol 1998;28:978-84.
16. Tacke AI, Kiyosawa K, Stark K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997;349:318-20.
17. Alannucci PA1. The choice of plasma-derived clotting factor concentrates. Ballims Clin Haematol 1996;9:273.
18. Allain JP, Dailey SH, Laurian Y, et al. Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs. J Clin Invest I991;88:1672-9.
19. Heringlake S, Ockenga J, Tillmann HL, et a!. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998;177:1723-6.
20. Bonacini M, Qian D, Govindarajan S, et al. Prevalence of hepatitis G virus RNA in the sera of patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:40-3.